SCHEMBL19978469

SCHEMBL19978469

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4ccc(C5(c6ccccc6)c6ccccc6-c6cccc7cccc5c67)cc4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
OPRK1 P41145 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 2/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
PDE6D O43924 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
PDK2 Q15119 1/20 0.31
DHFR P00374 4/20 0.30
TYMS P04818 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19978457 1.00 MEN1 (0.40) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978446 0.99 MEN1 (0.41) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978468 0.99 MEN1 (0.41) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978439 0.94 KDM4E (0.34) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978480 0.93 MEN1 (0.36) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978443 0.92 KDM4E (0.35) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978478 0.92 CA12 (0.36) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL19978461 0.92 CA12 (0.36) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL18680175 0.90 MAPT (0.33) MEN1KMT2AKDM4EMAPTLMNA
SCHEMBL17283646 0.90 PDK2 (0.35) MEN1KMT2AKDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10411191-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-10 US disclosed
US-20180083196-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-22 US disclosed
US-20180083196-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180083196-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 394/4885KMT2A 1848/4885KDM4E 3511/4885
US-10411191-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MEN1 394/4885KMT2A 1848/4885KDM4E 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.